Home › Funds › Vestal Point Capital, LP › AVTX

Vestal Point Capital, LP position in AVTX

AVALO THERAPEUTICS INC · Health Care

Vestal Point Capital, LP reported holding 800,000 shares of AVTX (AVALO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 0.32% of its reported portfolio and ranking #36 among its reported holdings. Vestal Point Capital, LP has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)800.00K sh
Reported value held$12.26M
Portfolio Weight0.32%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's AVTX position evolved

Vestal Point Capital, LP first disclosed a stake in AVTX in Q2 2026 at 775,000 shares (US$14.3M). Across 2 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 800,000 shares valued at US$12.3M — an increase of 25,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 775.00K $14.32M New
Q3 2026 800.00K $12.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVTX and 13F data

AVTX (AVALO THERAPEUTICS INC) is a Health Care company. 68 other funds we track also report a position in AVTX — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$60.9M), Deep Track Capital, LP (US$55.3M), Caligan Partners LP (US$50.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVTX

All AVTX fund holders →

FAQ

How long has Vestal Point Capital, LP held AVTX?

Vestal Point Capital, LP has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Vestal Point Capital, LP's current position in AVTX?

As of Q3 2026, Vestal Point Capital, LP holds 800.00K shares of AVTX (AVALO THERAPEUTICS INC), valued at $12.26M, representing 0.32% of its reported portfolio and ranking #36.

Has Vestal Point Capital, LP been buying or selling AVTX?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP increased its position in AVTX.

Which other funds hold AVTX?

Other major institutional holders of AVTX include FARALLON CAPITAL MANAGEMENT, L.L.C., Deep Track Capital, LP, Caligan Partners LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.